nafronyl has been researched along with Coronary Disease in 3 studies
Nafronyl: A drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1310) It may also be an antagonist at 5HT-2 serotonin receptors.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sensale, P | 1 |
| Reiterer, W | 1 |
| Breddin, HK | 1 |
1 review available for nafronyl and Coronary Disease
| Article | Year |
|---|---|
Current perspectives in the antiplatelet therapy of thrombotic disorders.
Topics: Angina, Unstable; Aspirin; Clinical Trials as Topic; Coronary Disease; Coronary Thrombosis; Humans; | 1989 |
2 trials available for nafronyl and Coronary Disease
| Article | Year |
|---|---|
[Effects of naftidrofuryl (Dusodril) on central hemodynamics and respiration].
Topics: Adult; Aged; Blood Pressure; Chronic Disease; Clinical Trials as Topic; Coronary Disease; Furans; He | 1975 |
Current perspectives in the antiplatelet therapy of thrombotic disorders.
Topics: Angina, Unstable; Aspirin; Clinical Trials as Topic; Coronary Disease; Coronary Thrombosis; Humans; | 1989 |
1 other study available for nafronyl and Coronary Disease
| Article | Year |
|---|---|
[The effect of naftidrofuryl on platelet aggregation].
Topics: Aged; Coronary Disease; Female; Furans; Humans; Male; Middle Aged; Nafronyl; Platelet Aggregation | 1980 |